title: Tacrine treatment in Alzheimer's disease enhances cerebral blood flow and mental status and decreases caregiver suffering.
authors.affiliation: Department of Gerontology, Virginia Commonwealth University, Richmond 23298-0266, USA. Harkins@gems.vcu.edu
authors.forename: S W
authors.initials: SW
authors.lastname: Harkins
authors.forename: J R
authors.initials: JR
authors.lastname: Taylor
authors.forename: V
authors.initials: V
authors.lastname: Mattay
authors.forename: W
authors.initials: W
authors.lastname: Regelson
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy*; D017028:Caregivers; D002560:Cerebrovascular Circulation / Q000187:drug effects; D006801:Humans; D008609:Mental Status Schedule; D009483:Neuropsychological Tests; D012039:Regional Blood Flow; D011795:Surveys and Questionnaires; D013619:Tacrine / Q000627:therapeutic use*
chemical_list: D013619:Tacrine